Cargando…
Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is low and varies with ethnicity. This study aimed to investigate the incidence of EGFR ge...
Autores principales: | Kim, Aeri, Jang, Min Hye, Lee, Soo Jung, Bae, Young Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500398/ https://www.ncbi.nlm.nih.gov/pubmed/28690651 http://dx.doi.org/10.4048/jbc.2017.20.2.150 |
Ejemplares similares
-
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
por: Teng, Yvonne Hui-Fang, et al.
Publicado: (2011) -
Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
por: Changavi, Arathi A, et al.
Publicado: (2015) -
Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China
por: Cao, Wen-Ming, et al.
Publicado: (2015) -
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
por: You, Kyu Sic, et al.
Publicado: (2021) -
Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Min Chong, et al.
Publicado: (2023)